Daratumumab–lenalidomide and the immunosuppressive budget in myeloma

The Lancet Oncology 2026

View at publisher

Authors: Yunfeng Fu, Junhua Zhang, Cong Xu

DOI: 10.1016/s1470-2045(25)00728-4

Cited by: 0

References: 1

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Chronic Lymphocytic Leukemia Research Bone health and treatments

References 1